Malignant melanoma - Interferon alpha: an important option in the therapy of high-risk patients

被引：0
作者：
不详
机构：
来源：
HAUTARZT | 2005年 / 56卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1190 / 1190
页数：1
相关论文
共 50 条
[31]   RANDOMIZED TRIAL OF ADJUVANT THERAPY FOR HIGH-RISK PRIMARY MALIGNANT-MELANOMA [J].
KAUFMAN, SD ;
CAREY, RW ;
COSIMI, AB ;
WOOD, WC .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR) :374-374
[32]   Combined adjuvant radiation and interferon-alpha 2B therapy in high-risk melanoma patients: The potential for increased radiation toxicity [J].
Hazard, LJ ;
Sause, WT ;
Noyes, RD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :796-800
[33]   Adjuvant Therapy for High-Risk Melanoma [J].
Tarhini, Ahmad A. .
AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (05) :4-13
[34]   Tandem Therapy as an Option for High-risk Neuroblastoma? [J].
von Baumgarten, Louisa .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2019, 87 (12) :680-681
[35]   Adjuvant Interferon in High-Risk Melanoma: End of the Era? [J].
Janku, Filip ;
Kurzrock, Razelle .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :E15-E16
[36]   LONG-TERM ADJUVANT THERAPY OF HIGH-RISK MALIGNANT-MELANOMA WITH RECOMBINANT INTERFERON ALFA-2B [J].
KOKOSCHKA, EM ;
TRAUTINGER, F ;
MISCKSCHE, M ;
KOKOSCHKA, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (04) :560-560
[37]   Cost-effectiveness of interferon for high-risk (stage III) melanoma patients [J].
Guillem, V ;
Alvarez-Mon, M ;
Camacho, F ;
Diaz-Perez, JL ;
Diaz-Rubio, E ;
Gonzalez-Larriba, JL ;
Lopez-Lopez, JJ ;
Moreno, JA ;
Serrano, S ;
Toribio, J .
EUROPEAN JOURNAL OF CANCER, 1999, 35 :S372-S372
[38]   Economic analysis of interferon for high-risk (stage III) melanoma patients. [J].
González-Larriba, JL ;
Alvarez-Mon, M ;
Camacho, F ;
Casado, MA ;
Díaz-Pérez, JL ;
Díaz-Rubio, E ;
Guillem, V ;
López-López, JJ ;
Moreno, JA ;
Serrano, S ;
Toribio, J .
EUROPEAN JOURNAL OF CANCER, 1999, 35 :S50-S50
[39]   FORMATION OF NEUTRALIZING ANTIBODIES AGAINST NATURAL INTERFERON-BETA, BUT NOT AGAINST RECOMBINANT INTERFERON-GAMMA DURING ADJUVANT THERAPY FOR HIGH-RISK MALIGNANT-MELANOMA PATIENTS [J].
DUMMER, R ;
MULLER, W ;
NESTLE, F ;
WIEDE, J ;
DUES, J ;
LECHNER, W ;
HAUBITZ, I ;
WOLF, W ;
BILL, E ;
BURG, G .
CANCER, 1991, 67 (09) :2300-2304
[40]   Adjuvant Interferon Therapy for Patients with Uveal Melanoma at High Risk of Metastasis [J].
Lane, Anne Marie ;
Egan, Kathleen M. ;
Harmon, David ;
Holbrook, Amy ;
Munzenrider, John E. ;
Gragoudas, Evangelos S. .
OPHTHALMOLOGY, 2009, 116 (11) :2206-2212
12345